Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05656235
What this trial is testing

Renal Retention in High Grade Upper Tract Urothelial Cancer

Who this might be right for
High Grade Urothelial CarcinomaBladder CancerUrothelial Carcinoma Bladder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT02039310
What this trial is testing

Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy

Who this might be right for
Bladder Cancer
University of Michigan 59
Testing effectiveness (Phase 2)Looking for participantsNCT06528990
What this trial is testing

Telehealth Intervention for Ostomy Self-Management

Who this might be right for
Colorectal CancerBladder Cancer
City of Hope Medical Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Large-scale testing (Phase 3)UnknownNCT00553124
What this trial is testing

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital Birmingham 3,400
Testing effectiveness (Phase 2)Looking for participantsNCT07647289
What this trial is testing

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital 58
Not applicableLooking for participantsNCT05102110
What this trial is testing

Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Who this might be right for
Non Small Cell Lung CancerPancreatic CancerBladder Cancer+1 more
Origin Sciences 450
Testing effectiveness (Phase 2)Study completedNCT01599013
What this trial is testing

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

Who this might be right for
Bladder Transitional Cell Carcinoma Stage IV
Pierre Fabre Medicament 69
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Not applicableLooking for participantsNCT04442724
What this trial is testing

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Who this might be right for
Bladder CancerUrinary Bladder NeoplasmUrologic Neoplasms+2 more
Cedars-Sinai Medical Center 60
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Early research (Phase 1)Looking for participantsNCT06186414
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Jiangsu Simcere Pharmaceutical Co., Ltd. 152
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)Ended earlyNCT06630247
What this trial is testing

A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more
Exelixis 9
Testing effectiveness (Phase 2)Study completedNCT01520038
What this trial is testing

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 2
Early research (Phase 1)Looking for participantsNCT07660055
What this trial is testing

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Who this might be right for
Breast CancerNon-small Cell Lung Cancer (NSCLC)Gastric/Gastroesophageal Junction (GEJ) Cancer+1 more
Novartis Pharmaceuticals 156
Not applicableEnrolling By InvitationNCT05195515
What this trial is testing

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

Who this might be right for
Bladder Cancer
Aarhus University Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT01684098
What this trial is testing

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Who this might be right for
Recurrent or Metastatic CancerHead and Neck CancerPancreas Cancer+2 more
Endocyte 40
Testing effectiveness (Phase 2)Looking for participantsNCT05327647
What this trial is testing

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
CHU de Quebec-Universite Laval 160
Not applicableStudy completedNCT06688643
What this trial is testing

The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit

Who this might be right for
Bladder Cancer
Xiaguang Duan 58
Next Page